跳至主要内容
临床试验/NL-OMON50052
NL-OMON50052已完成不适用

Pharmacokinetic and pharmacodynamic target attainment of ceftazidime in adult patients on general wards with different degrees of renal function: a prospective observational cohort study - Target attainment of ceftazidime

Academisch Medisch Centrum0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • Receiving ceftazidime therapy intravenous (iv) as part of standard care
  • Age * 18 years
  • Admitted to a general ward of Amsterdam UMC - location AMC or Noordwest
  • Ziekenhuisgroep location Alkmaar
  • Informed consent is obtained

排除标准

  • Mentally incapacitated patients , i.e. a minor or legally incompetent adult
  • Renal replacement therapy during treatment with ceftazidime
  • Patients admitted to the intensive care unit (ICU)
  • Severely burned patients, defined as a burned surface * 10%
  • Patients with cystic fibrosis
  • Informed consent is not obtained

研究者

相似试验